The NemetzGroup

Connecting the Dots

A life sciences podcast for biopharma leaders on surviving the realities of commercialization.

Husk at besøge podcastens hjemmeside og støtte skaberen: connectingthedotspodcast.libsyn.com

Forfatter

The NemetzGroup

Kategori

Science

Podcastens hjemmeside

connectingthedotspodcast.libsyn.com

Seneste episode

25. sep. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Hent den på Google Play Installer gratis Android næsten 10 mio. downloads · 4,8 i bedømmelse iOS snart

Episoder

Three Big Mistakes 26.09.2023
What's The Latest? 17.08.2023
Gen Z Advice for Seasoned Boomers 25.07.2023
Find Your Own Light 21.06.2023
Running The Biopharma Marathon 13.04.2023
"Rare Disease" Is More Than Just a Day 13.02.2023
Moving Beyond The One-Hit Wonder 08.12.2022
Optimizing Collaboration between Commercial and Medical Affairs 04.11.2022
The Importance of a Commercialization Mindset 27.09.2022
Be Bold and Take Risks 26.07.2022
Optimize Your Congress Planning 27.06.2022
Communicating Without A Communication Leader 25.05.2022
Appreciation for Interconnectedness 15.03.2022
Moments That Matter 25.10.2021
Commercialization - A Mindset, Not a Function 27.09.2021
Start Too Early... Before it's Too Late 26.07.2021
Freedom to Lead 16.06.2021
Pandemic-Inspired Thought Bubbles 13.05.2021
Solving the Hiring Puzzle 26.04.2021
Notes from the Un-Empty Nest 26.03.2021
Rare Diseases — It's All About the Patient 21.02.2021
Planning Amidst the Mayhem 25.01.2021
My Big Announcement 16.12.2020
Reverse Mentoring with Up-and-Coming Talent 28.10.2020
Commercialization Street Smarts to Inform Your S-1 Business Section 30.09.2020

Lyt til podcasten Connecting the Dots i Replaio

Radio og podcasts i én app - gratis og uden tilmelding. Installer i dag, og gå ikke glip af lanceringen

Hent den på Google Play

Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.